Alteogen is a leading biopharmaceutical company with a robust pipeline of next-generation biologics featuring enhanced efficacy, enabled by its proprietary platform technologies. Founded in 2008, the company is listed on the KOSDAQ stock exchange (KRX:196170).
Alteogen’s most distinguished platform, Hybrozyme™, is a novel human hyaluronidase technology that enhances the absorption of biologic drugs administered via subcutaneous injection. This proprietary hyaluronidase demonstrates improved enzymatic activity and thermal stability compared to existing alternatives.
Another key innovation, NexP™ fusion technology, is designed to extend the half-life of therapeutic proteins and peptides in the human body. It is currently applied to the development of long-acting biologics, including human growth hormone, exenatide (for diabetes), and Factor VIIa (for hem
Alteogen’s most distinguished platform, Hybrozyme™, is a novel human hyaluronidase technology that enhances the absorption of biologic drugs administered via subcutaneous injection. This proprietary hyaluronidase demonstrates improved enzymatic activity and thermal stability compared to existing alternatives.
Another key innovation, NexP™ fusion technology, is designed to extend the half-life of therapeutic proteins and peptides in the human body. It is currently applied to the development of long-acting biologics, including human growth hormone, exenatide (for diabetes), and Factor VIIa (for hemophilia).
The company’s proprietary antibody-drug conjugate platform, NexMab™ ADC technology, enables targeted cancer therapies with improved efficacy and reduced side effects. Using this platform, Alteogen is developing ADC therapeutics for breast, gastric, and ovarian cancers.
With extensive expertise and experience, Alteogen has also established its own high-expression cell lines, efficient upstream and downstream processes, and optimized analytical methods to support the development of monoclonal antibody biosimilars.
Company Details
- Employees
- 37
- Founded
- -
- Address
- 62, Yuseong-Daero 1628beon-Gil, Yuseong-Gu,daejeon 34054,korea, Republic Of
- Phone
- +82-42-384-8780
- Industry
- Biotechnology
- Website
- alteogen.com
- Keywords
- Lifecycle Management, Novel Hyaluronidase, Biobetter, Biotechnology, Growth Hormone, Biosimilar, ADC.
- HQ
- Yuseong-gu, Daejeon
Alteogen Questions
Alteogen's helpline number is +82-42-384-8780
Alteogen's website is alteogen.com
Alteogen's LinkedIn profile is https://kr.linkedin.com/company/alteogen
Alteogen has
37 employees.
View email and phone details for 37
employees at Alteogen.
Alteogen's industry is
Biotechnology
Alteogen's top competitors are
Astrazeneca,
Esobiotec,
리가켐바이오,
Yuhan Corporation,
Hanmi Pharmaceuticals,
Daiichi Sankyo Us,
Peptron, Inc.,
Argenx,
Curocell,
Abl Bio Inc..
Alteogen's categories are Biotechnology
Alteogen's founding year is 2008
